Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes

被引:13
作者
Tomita, Y
Avila-Cariño, J
Yamamoto, K
Mellstedt, H
Klein, E [1 ]
机构
[1] Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17177 Stockholm, Sweden
[2] Karolinska Hosp, Radiumhemmet, Dept Oncol, S-17176 Stockholm, Sweden
关键词
B-CLL; Epstein-Barr virus; autologous T lymphocytes; cell mediated recognition;
D O I
10.1016/S0165-2478(97)00142-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We compared 5-day-old cultures of two B-CLL clones experimentally infected with EBV for their interaction with autologous T lymphocytes. The clone which was strongly activated by the virus stimulated autologous T cells. It was also damaged by the cytotoxic T cells which were generated in mixed cultures with autologous lymphoblastoid cell lines (LCL). Cultured, non-infected CLL cells were not lysed by these effecters. The other B-CLL clone, which was activated to considerably lesser extent by the virus, did not stimulate the autologous T lymphocytes. While, also in this case cytotoxic function was generated in the mixed T cell-LCL culture, the effecters did not damage the EBV-infected CLL cells. The results with B-CLL cells can be regarded as a model for the EBV genome carrier normal B lymphocytes. They substantiate the current concept that such cells persist in seropositive healthy individuals undisturbed by the specific immune response as long as they maintain the phenotype of resting cells. However, after activation they can be recognized and eliminated by T cells. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 36 条
[1]   COMBINED TREATMENT WITH INTERFERON (IFN)-GAMMA AND TUMOR NECROSIS FACTOR (TNF)-ALPHA UP-REGULATES THE EXPRESSION OF HLA CLASS-I DETERMINANTS IN BURKITT-LYMPHOMA LINES [J].
AVILACARINO, J ;
TORSTEINSDOTTIR, S ;
BEJARANO, MT ;
KLEIN, G ;
KLEIN, E ;
MASUCCI, MG .
CELLULAR IMMUNOLOGY, 1988, 117 (02) :303-311
[2]   EBV INFECTION OF B-CLL CELLS IN-VITRO POTENTIATES THEIR ALLOSTIMULATORY CAPACITY IF ACCOMPANIED BY ACQUISITION OF THE ACTIVATED PHENOTYPE [J].
AVILACARINO, J ;
LEWIN, N ;
YAMAMOTO, K ;
TOMITA, Y ;
MELLSTEDT, H ;
BRODIN, B ;
ROSEN, A ;
KLEIN, E .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (05) :678-685
[3]  
AvilaCarino J, 1997, INT J CANCER, V70, P1, DOI 10.1002/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO
[4]  
2-1
[5]   B-CLL cells experimentally infected with EBV enter DNA synthesis, produce cytokines and stimulate T-lymphocytes [J].
AvilaCarino, J ;
Andersson, J ;
Mellstedt, H ;
Klein, E .
IMMUNOLOGY LETTERS, 1996, 54 (01) :45-52
[6]   SEARCH FOR THE CRITICAL CHARACTERISTICS OF PHENOTYPICALLY DIFFERENT B-CELL LINES, BURKITT-LYMPHOMA CELLS AND LYMPHOBLASTOID CELL-LINES, WHICH DETERMINE DIFFERENCES IN THEIR FUNCTIONAL INTERACTION WITH ALLOGENEIC LYMPHOCYTES [J].
AVILACARINO, J ;
TORSTEINSDOTTIR, S ;
EHLINHENRIKSSON, B ;
MASUCCI, MG ;
KLEIN, E .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 34 (02) :128-132
[7]  
CARLSSON M, 1989, LEUKEMIA, V3, P593
[8]   A SUBPOPULATION OF NORMAL B-CELLS LATENTLY INFECTED WITH EPSTEIN-BARR-VIRUS RESEMBLES BURKITT-LYMPHOMA CELLS IN EXPRESSING EBNA-1 BUT NOT EBNA-2 OR LMP1 [J].
CHEN, F ;
ZOU, JZ ;
DIRENZO, L ;
WINBERG, G ;
HU, LF ;
KLEIN, E ;
KLEIN, G ;
ERNBERG, I .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3752-3758
[9]   POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS [J].
CRAIG, FE ;
GULLEY, ML ;
BANKS, PM .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 99 (03) :265-276
[10]   EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN POSITIVE LYMPHOMA AFTER CYCLOSPORIN-A TREATMENT IN PATIENT WITH RENAL-ALLOGRAFT [J].
CRAWFORD, DH ;
THOMAS, JA ;
JANOSSY, G ;
SWENY, P ;
FERNANDO, ON ;
MOORHEAD, JF ;
THOMPSON, JH .
LANCET, 1980, 1 (8182) :1355-1356